ATE193440T1 - Arzneimittel für insulinresistente diabetiker - Google Patents

Arzneimittel für insulinresistente diabetiker

Info

Publication number
ATE193440T1
ATE193440T1 AT90905048T AT90905048T ATE193440T1 AT E193440 T1 ATE193440 T1 AT E193440T1 AT 90905048 T AT90905048 T AT 90905048T AT 90905048 T AT90905048 T AT 90905048T AT E193440 T1 ATE193440 T1 AT E193440T1
Authority
AT
Austria
Prior art keywords
insulin
medicinal products
dietary supplement
diabetic people
resistant diabetic
Prior art date
Application number
AT90905048T
Other languages
English (en)
Inventor
Joseph Larner
Allison Kennington
Original Assignee
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia filed Critical Univ Virginia
Application granted granted Critical
Publication of ATE193440T1 publication Critical patent/ATE193440T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90905048T 1989-03-08 1990-03-08 Arzneimittel für insulinresistente diabetiker ATE193440T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32048289A 1989-03-08 1989-03-08
PCT/US1990/001109 WO1990010439A1 (en) 1989-03-08 1990-03-08 Dietary supplement for insulin-resistant diabetics

Publications (1)

Publication Number Publication Date
ATE193440T1 true ATE193440T1 (de) 2000-06-15

Family

ID=23246630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905048T ATE193440T1 (de) 1989-03-08 1990-03-08 Arzneimittel für insulinresistente diabetiker

Country Status (10)

Country Link
US (1) US5124360A (de)
EP (1) EP0465508B1 (de)
JP (3) JPH04504847A (de)
AT (1) ATE193440T1 (de)
AU (1) AU647735B2 (de)
CA (1) CA2047686C (de)
DE (1) DE69033560T2 (de)
DK (1) DK0465508T3 (de)
ES (1) ES2146197T3 (de)
WO (1) WO1990010439A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
EP0568545A4 (en) * 1991-01-23 1993-11-24 The University Of Virginia Patents Foundation Method of reducing elevated blood sugar levels in humans
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
TW282398B (de) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
RU2121353C1 (ru) * 1995-05-29 1998-11-10 Иван Петрович Чепурной Способ коррекции углеводного обмена в организме человека (варианты)
US6086882A (en) * 1997-08-06 2000-07-11 National Institute For Pharmaceutical Research Phytodrug for management of peptic ulcer and methods of preparing and using same
DE19707756A1 (de) * 1997-02-26 1998-08-27 Georgios Dr Pandalis Präparat auf der Basis von Kichererbsenpflanzen oder -pflanzenteilen
NZ337927A (en) * 1997-03-24 2000-11-24 Galderma Res & Dev Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds
US6492341B1 (en) 1997-05-07 2002-12-10 Cornell Research Foundation, Inc. Preparation of fagopyritols and uses therefor
CA2236641C (en) * 1997-05-07 2008-07-15 Cornell Research Foundation, Inc. Preparation of fagopyritols and uses therefor
US20010039297A1 (en) * 1998-05-19 2001-11-08 Insmed Pharmaceuticals, Inc. Compositions and method for improving insulin sensivity and glucose metabolism in individuals with impaired fasting glucose or impaired glucose tolerance
EP1183021A4 (de) 1999-05-20 2004-09-15 Humanetics Corp Stimulation des glukosetransports ins tierische gewebe durch verabreichung von pinotol
US6784209B1 (en) * 1999-10-18 2004-08-31 Muscletech Research And Development Inc. Food supplement for increasing lean mass and strength
RU2002111408A (ru) * 1999-10-18 2004-05-20 Мусклетеч Ресеч Энд Девелопмент Инк. (Ca) Пищевая добавка для увеличения мышечной массы и силы
AU2001239826B2 (en) * 2000-02-23 2006-06-15 Orentreich Foundation For The Advancement Of Science, Inc. Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
KR20010091341A (ko) * 2000-03-14 2001-10-23 신용철 카이로이노시톨 추출물을 유효성분으로 함유하는 의약조성물
US6660891B2 (en) 2000-05-15 2003-12-09 Insmed Incorporated Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
US6486127B1 (en) * 2001-05-23 2002-11-26 Insmed, Incorporated Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
US6492339B1 (en) * 2001-05-23 2002-12-10 Insmed, Incorporated Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof
CA2483550C (en) 2002-05-09 2016-06-28 Cornell Research Foundation, Inc. Fagopyrum esculentum fagopyritol synthase gene and use thereof
US20060004096A1 (en) * 2004-05-28 2006-01-05 Joseph Larner Method of Treating Endothelial Dysfunction, Oxidative Stress and Related Diseases
US20060258754A1 (en) * 2004-05-28 2006-11-16 Joseph Larner Method of treating endothelial dysfunction, oxidative stress and related diseases
JP2007068476A (ja) * 2005-09-08 2007-03-22 Hokko Chem Ind Co Ltd 健康食品およびｄ−キロ−イノシトールを得る方法
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AR074797A1 (es) * 2008-10-10 2011-02-16 Japan Tobacco Inc Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
JP6244065B1 (ja) 2016-04-27 2017-12-06 小林製薬株式会社 育毛剤
JP6838146B2 (ja) 2016-10-06 2021-03-03 ディーワイ ナチュラル カンパニー リミテッド ピニトール、ｄ−カイロ−イノシトール、又はこれらの類似化合物を有効成分として含む、女性の更年期症状の改善、予防、又は治療用の組成物
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
WO2019101368A1 (en) 2017-11-23 2019-05-31 Biosearch, S.A. Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JPH03138126A (ja) * 1989-10-24 1991-06-12 Mitsubishi Gas Chem Co Inc 均一薄肉中空成形品の射出成形方法

Also Published As

Publication number Publication date
DE69033560D1 (de) 2000-07-06
JP2002249427A (ja) 2002-09-06
WO1990010439A1 (en) 1990-09-20
EP0465508A4 (en) 1992-05-13
AU5280890A (en) 1990-10-09
CA2047686C (en) 2000-09-05
JPH04504847A (ja) 1992-08-27
EP0465508A1 (de) 1992-01-15
CA2047686A1 (en) 1990-09-09
EP0465508B1 (de) 2000-05-31
DK0465508T3 (da) 2000-08-07
AU647735B2 (en) 1994-03-31
DE69033560T2 (de) 2001-03-01
US5124360A (en) 1992-06-23
JP2000219624A (ja) 2000-08-08
ES2146197T3 (es) 2000-08-01

Similar Documents

Publication Publication Date Title
ATE193440T1 (de) Arzneimittel für insulinresistente diabetiker
Sullivan Jr et al. Acute carbamazepine toxicity resulting from overdose
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
Di Benedetto Chronic hypervitaminosis A in an adult
Goodhart et al. The role of nutritional deficiencies in the production of cardiovascular disturbances in the alcohol addict
Melander et al. Clinical pharmacology of glipizide
Weller Neuropsychiatric symptoms following bismuth intoxication
Bean et al. Vitamin deficiencies in diarrheal states
Sindoni Fasting blood sugar vs. postprandial blood sugar as observed in normal individuals, medical (non-diabetic) patients, and patients with diabetes: special references to: plain, protamine zinc and globin insulins, compatible hyperglycemia and arteriosclerosis
Silverstone Clinical use of appetite suppressants.
Mandelbaum et al. Hypothyroidism, hyperlipemia and carotenemia
Hultgren et al. Clinical and experimental study of use of khellin in treatment of angina pectoris
Kamimura Comparison of alpha-tocopheryl nicotinate and acetate on skin microcirculation
Rachmilewitz et al. The presence of electrocardiographic changes in nicotinic acid deficiency and their elimination by nicotinic acid
Rachmilewitz et al. Electrocardiographic changes and the effect of niacin therapy in pellagra
ZIEVE et al. Vitamin unresponsiveness: progression of classic signs of neuropathy and pellagra during therapy
Begg Sulphaemoglobinaemia
STRYKER et al. Determination of macrocytic anemia as an aid in diagnosis of certain deficiency dermatoses
JPS56108712A (en) Lecithin cholesterol acyl transferase activator
Brown The effect of egg white and crystalline biotin methyl ester on a skin lesion in three infants
KAYE et al. Antipyretics in patients with juvenile diabetes mellitus: comparison of salicylate and a salicylate substitute (experimental preparation PAJ-102)
GUTENKAUF Beriberi heart in Iowa veterans
Brown Glossitis Following the Administration of Sulphanilamide and Sulphathiazole: Report of Two Cases
SU1266543A1 (ru) Способ лечени протейного дисбактериоза
Spesivtseva et al. Use of high-purity insulins in the treatment of patients with diabetes mellitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee